Core Viewpoint - C3.ai, Inc. is facing a class action lawsuit due to allegations of misleading statements regarding its growth and the impact of its CEO's health on the company's performance [3][4]. Summary by Relevant Sections Allegations - The complaint claims that C3.ai's management provided overly positive statements while concealing material adverse facts about the company's growth, particularly the CEO's health affecting deal closures [3]. - The company announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to "the reorganization with new leadership" and the CEO's health [3]. Stock Price Impact - Following the announcement of poor financial results, C3.ai's stock price dropped significantly from $22.13 per share on August 8, 2025, to $16.47 per share on August 11, 2025, marking a decline of approximately 25.58% in just one day [3]. Class Action Details - Shareholders who purchased shares during the class period from February 26, 2025, to August 8, 2025, are encouraged to register for the class action, with a deadline of October 21, 2025, to seek lead plaintiff status [4]. - Participants will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [4]. Law Firm Information - The Gross Law Firm, a nationally recognized class action law firm, is representing the shareholders, focusing on protecting investors from deceit and fraud [5].

Core Points - The article highlights the upcoming deadline of October 21, 2025, for investors to file a lead plaintiff motion in a class action lawsuit concerning C3.ai, Inc. [1] - The class action is on behalf of investors who purchased or acquired C3.ai securities during the specified Class Period from February 26, 2025, to August 8, 2025 [1] Company Information - C3.ai, Inc. is identified as a publicly traded company on the NYSE under the ticker symbol AI [1] - The article indicates that investors who suffered losses on their C3.ai investments are encouraged to inquire about pursuing claims to recover their losses [1]

CONTACT US HERE: https://securitiesclasslaw.com/securities/c3-ai-inc-loss-submission-form-2/?id=166899&from=4 CLASS PERIOD: February 26, 2025 to August 8, 2025 ALLEGATIONS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of C3 AI's growth; notably, that its Chief Executive Officer health was having a significant i ...

NEW YORK, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Snap Inc. (“Snap” or the “Company”) (NYSE: SNAP) between April 29, 2025 and August 5, 2025, inclusive. Should You Join This Class Action Lawsuit? Do you, or did you, own shares of C3.ai, Inc. (NYSE: AI)?Did you purchase your shares between February 26, 2025 and August 8, 2025, inclusive?Di ...

The company's CEO had to step aside due to an unexpected cause.There have been significant changes at C3.ai (AI 0.27%); investors need to be aware of the latest developments.*Stock prices used were the afternoon prices of Sept. 11, 2025. The video was published on Sept. 13, 2025. ...

Market Overview - Major indexes such as the Dow, S&P, and Nasdaq are near all-time highs, with the Russell 2000 at year-to-date highs, indicating a significant market recovery since early April [1][2] - From the lows on April 7, 2023, the Dow has increased by 25.9%, the S&P by 36.2%, the Nasdaq by 49.1%, and the Russell 2000 by 39.7% [2] Historical Context - The S&P 500 experienced a 23.3% increase last year, marking the second consecutive year of over 20% gains, a rare occurrence since 1995-1996 [4] - The historical performance of the S&P during the dot-com boom saw substantial annual gains, with a total increase of 220% over five years [5] Current Economic Indicators - Recent inflation data shows core inflation at 3.1% year-over-year, with the Producer Price Index easing to 2.8% [10][11] - The Federal Reserve is expected to cut interest rates, with nearly 100% odds of a cut, potentially by 50 basis points [13][14] Earnings Outlook - Earnings growth remains strong, with S&P earnings up 12.5% in Q2 2025 and forecasts of continued growth in subsequent quarters [16][17] - Despite previous concerns over tariffs and recession, aggregate earnings estimates indicate resilience and growth potential [17] Small-Cap Performance - The small-cap sector is experiencing a rally, supported by anticipated interest rate cuts and favorable tax provisions from recent budget legislation [18][20] - Small-caps are expected to benefit significantly from lower borrowing costs and immediate expensing of capital expenditures [19][20] Technology Sector - The current market is witnessing a tech boom driven by Artificial Intelligence (AI), which is anticipated to be transformative across various industries [7][8] - The AI trade is supported by real earnings and growth potential, contributing to a positive market outlook [8] Investment Strategies - Proven stock-picking strategies, such as focusing on Zacks Rank 1 Strong Buy stocks, have historically outperformed the market [23][24] - Strategies targeting small-cap growth and stocks making new highs have shown significant returns compared to the broader market [28][29]

Core Viewpoint - A class action lawsuit has been filed against C3.ai, Inc. for allegedly misleading investors about the impact of its CEO's health on the company's business prospects [1][2]. Allegations - The complaint claims that during the class period, C3.ai did not disclose how the CEO's health affected the company's ability to close deals and that management was ineffective in mitigating this impact [2]. - The lawsuit alleges that C3.ai would struggle to achieve its profit and growth potential due to these undisclosed issues [2]. Financial Impact - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing the poor performance to "the reorganization with new leadership" and the CEO's health issues [3]. - Following this announcement, C3.ai's stock price dropped from $22.13 per share on August 8, 2025, to $16.47 per share on August 11, 2025, marking a decline of over 25% [3]. Next Steps for Shareholders - Shareholders interested in participating in the class action must submit their papers to the court by October 21, 2025, to serve as lead plaintiff [4]. - Shareholders can choose to remain absent from the case while still being eligible for recovery [4].

Group 1 - UBS raised its price target on c3.ai to $17 from $16 while maintaining a Neutral rating due to ongoing uncertainty regarding growth trajectory and execution risks [1] - The firm expressed caution regarding FY27 revenue outcomes, with investor expectations ranging from flat growth to mid-20% expansion [1] - c3.ai's Q1 miss was attributed to execution issues on large deals rather than widespread weakness, but new leadership changes have introduced uncertainty [1] Group 2 - UBS noted that the FY26 revenue framework of $290 million to $300 million seemed conservative, but the lack of a finalized strategy under the new CEO could disrupt performance over several quarters [2] - The firm kept its FY26 revenue estimate unchanged at $299 million [2] - Visibility into the second half of FY26 and into FY27 remains limited, and despite negative investor positioning, UBS prefers to remain cautious until more clarity is available [2]

C3.ai (AI) is a leading provider of enterprise artificial intelligence (AI) software, enabling global organizations to accelerate their digital transformation through advanced AI solutions. The company offers a robust platform and over 130 turnkey AI applications tailored for industries such as manufacturing, energy, financial services, defense, and government. C3.ai empowers clients, including Fortune 500 firms and federal agencies, to optimize operations, anticipate challenges, and unlock actionable insi ...

Core Viewpoint - A class action securities lawsuit has been filed against C3.ai, Inc. due to alleged securities fraud impacting investors between February 26, 2025, and August 8, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that C3.ai's management provided misleading positive statements while concealing adverse facts about the company's growth, particularly regarding the health of its CEO and its impact on deal closures [2]. - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to "the reorganization with new leadership" and the CEO's health [2]. - Following the announcement, C3.ai's stock price dropped from $22.13 per share on August 8, 2025, to $16.47 per share on August 11, 2025, marking a decline of approximately 25.58% in just one day [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until October 21, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].